These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26650149)

  • 1. Postoperative Use of Anti-TNF-α Agents in Patients with Crohn's Disease and Risk of Reoperation-A Nationwide Cohort Study.
    Kjeldsen J; Nielsen J; Larsen MD; Qvist N; Nørgård BM
    Inflamm Bowel Dis; 2016 Mar; 22(3):599-606. PubMed ID: 26650149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.
    Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
    Aliment Pharmacol Ther; 2013 Jan; 37(2):214-24. PubMed ID: 23190161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiopurines are associated with a reduction in surgical re-resections in patients with Crohn's disease: a long-term follow-up study in a regional and academic cohort.
    van Loo ES; Vosseberg NW; van der Heide F; Pierie JP; van der Linde K; Ploeg RJ; Dijkstra G; Nieuwenhuijs VB
    Inflamm Bowel Dis; 2013 Dec; 19(13):2801-8. PubMed ID: 24189041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors associated with postoperative recurrence and repeat surgery in Japanese patients with Crohn's disease.
    Kusaka J; Shiga H; Kuroha M; Kimura T; Kakuta Y; Endo K; Kinouchi Y; Shimosegawa T
    Int J Colorectal Dis; 2017 Oct; 32(10):1407-1413. PubMed ID: 28735411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crohn's disease recurrence after total proctocolectomy with definitive ileostomy.
    Amiot A; Gornet JM; Baudry C; Munoz-Bongrand N; Auger M; Simon M; Allez M; Cattan P; Sarfati E; Lémann M
    Dig Liver Dis; 2011 Sep; 43(9):698-702. PubMed ID: 21474398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study.
    Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1301-9. PubMed ID: 22506582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative Morbidity Risks Following Ileocolic Resection for Crohn's Disease Treated With Anti-TNF Alpha Therapy: A Retrospective Study of 360 Patients.
    Jouvin I; Lefevre JH; Creavin B; Pitel S; Chafai N; Tiret E; Beaugerie L; Parc Y;
    Inflamm Bowel Dis; 2018 Jan; 24(2):422-432. PubMed ID: 29361093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.
    Fumery M; Seksik P; Auzolle C; Munoz-Bongrand N; Gornet JM; Boschetti G; Cotte E; Buisson A; Dubois A; Pariente B; Zerbib P; Chafai N; Stefanescu C; Panis Y; Marteau P; Pautrat K; Sabbagh C; Filippi J; Chevrier M; Houze P; Jouven X; Treton X; Allez M;
    Am J Gastroenterol; 2017 Feb; 112(2):337-345. PubMed ID: 27958285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable outcomes of the consistent use versus switched use of anti- tumor necrosis factor agents in postoperative recurrent Crohn's disease following ileocolonic resection.
    Li Y; Stocchi L; Rui Y; Remzi FH; Shen B
    Int J Colorectal Dis; 2016 Nov; 31(11):1751-1758. PubMed ID: 27475090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.
    Fréling E; Baumann C; Cuny JF; Bigard MA; Schmutz JL; Barbaud A; Peyrin-Biroulet L
    Am J Gastroenterol; 2015 Aug; 110(8):1186-96. PubMed ID: 26195181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-TNF Therapy Is Associated With an Increased Risk of Postoperative Morbidity After Surgery for Ileocolonic Crohn Disease: Results of a Prospective Nationwide Cohort.
    Brouquet A; Maggiori L; Zerbib P; Lefevre JH; Denost Q; Germain A; Cotte E; Beyer-Berjot L; Munoz-Bongrand N; Desfourneaux V; Rahili A; Duffas JP; Pautrat K; Denet C; Bridoux V; Meurette G; Faucheron JL; Loriau J; Guillon F; Vicaut E; Benoist S; Panis Y;
    Ann Surg; 2018 Feb; 267(2):221-228. PubMed ID: 29300710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
    Absah I; Faubion WA
    Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of Preoperative Medications on Postoperative Complications in Patients After Intestinal Surgery for Crohn's Disease.
    Yu CS; Jung SW; Lee JL; Lim SB; Park IJ; Yoon YS; Kim CW; Yang SK; Ye BD; Park SH; Han M; Kim JC
    Inflamm Bowel Dis; 2019 Aug; 25(9):1559-1568. PubMed ID: 30753560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti tumour necrosis factor as risk factor for free perforations in Crohn's disease? A case-control study.
    Eshuis EJ; Griffioen GH; Stokkers PC; Ubbink DT; Bemelman WA
    Colorectal Dis; 2012 May; 14(5):578-84. PubMed ID: 21848898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive histopathologic phenotype in resection specimens from patients with Crohn's disease receiving anti-TNF-α therapy.
    Schaeffer DF; Walsh JC; Kirsch R; Waterman M; Silverberg MS; Riddell RH
    Hum Pathol; 2014 Sep; 45(9):1928-35. PubMed ID: 25022570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Anti-Tumor Necrosis Factor Alpha Therapy on Postoperative Complications in Pediatric Crohn's Disease.
    Dotlacil V; Bronsky J; Hradsky O; Frybova B; Coufal S; Skaba R; Rygl M
    Eur J Pediatr Surg; 2020 Feb; 30(1):27-32. PubMed ID: 31600799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.
    Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1494-502.e1. PubMed ID: 24440221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.
    Carla-Moreau A; Paul S; Roblin X; Genin C; Peyrin-Biroulet L
    Dig Liver Dis; 2015 Mar; 47(3):191-6. PubMed ID: 25488057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
    Syed A; Cross RK; Flasar MH
    Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.